Literature DB >> 172531

Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.

D W Bilheimer, J L Goldstein, S M Grundy, M S Brown.   

Abstract

The turnover of 125I-labeled low density lipoprotein (LDL) and the total body balance of cholestrol were studied in a 6-yr-old girl with the homozygous form of familial hypercholesterolemia (FH) before and after the surgical creation of an end-to-side portacaval shunt. The results were compared with those of similar studies simultaneously performed in untreated patients with the heterozygous form of FH and with the results of earlier studies performed on normolipidemic subjects. Before shunt surgery, the rate of synthesis of LDL in the FH homozygote (mg/kg per day) was fourfold higher than in normolipidemic subjects and twofold higher than in her heterozygous mother. The fractional catabolic rate for LDL in the homozygote was decreased to 33% of normal control values. The rate of cholesterol synthesis, estimated by chemical sterol balance, was higher in the FH homozygote than in two FH heterozygotes of similar age studied simultaneously. When considered in relation to the markedly elevated level of plasma cholesterol, the observed rate of cholesterol synthesis in the FH homozygote was inappropriately elevated. Bile acid production was normal in all three children. 5 mo after shunt surgery, the rate of LDL synthesis in the homozygote had declined by 48% as compared with the preoperative value, and this caused a 39% drop in the plasma LDL cholesterol level despite a 17% reduction in the fractional catabolic rate of the lipoprotein. The rate of cholesterol synthesis fell by 62% as compared with the preoperative value. The findings of an inappropriately elevated rate of production of both cholesterol and LDL as well as a reduced fractional catabolic rate for the lipoprotein in the untreated FH homozygote are consistent with results of studies in cultured fibroblasts indicating that the primary genetic defect in FH involves a deficiency in a cell-surface receptor for LDL that regulates both cholesterol synthesis and LDL degradation. Although the mechanism for the decline in production of cholesterol and LDL after portacaval shunt surgery is unknown, it was observed that these changes were associated with marked increases in the plasma concentrations of bile acids and glucagon.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172531      PMCID: PMC333120          DOI: 10.1172/JCI108223

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Cholesterol synthesis by cultured fibroblasts: decreased feedback inhibition in familial hypercholesterolemia.

Authors:  A K Khachadurian; F S Kawahara
Journal:  J Lab Clin Med       Date:  1974-01

Review 3.  The regulation of cholesterol metabolism as related to familial hypercholesterolaemia.

Authors:  N B Myant
Journal:  Sci Basis Med Annu Rev       Date:  1970

4.  Cholesterol metabolism in patients with coronary heart disease.

Authors:  T A Miettinen
Journal:  Ann Clin Res       Date:  1971-12

5.  The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine.

Authors:  C D Moutafis; N B Myant
Journal:  Clin Sci       Date:  1969-10       Impact factor: 6.124

6.  Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism.

Authors:  S M Grundy; E H Ahrens; G Salen
Journal:  J Lab Clin Med       Date:  1971-07

7.  Studies in the metabolism of cholesterol in subjects with normal plasma cholesterol levels and in patients with essential hypercholesterolaemia.

Authors:  B Lewis; N B Myant
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

8.  Cholesterol ester formation in cultured human fibroblasts. Stimulation by oxygenated sterols.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

9.  An evaluation of four methods for measuring cholesterol absorption by the intestine in man.

Authors:  E Quintão; S M Grundy; E H Ahrens
Journal:  J Lipid Res       Date:  1971-03       Impact factor: 5.922

10.  Studies of pancreatic alpha cell function in normal and diabetic subjects.

Authors:  R H Unger; E Aguilar-Parada; W A Müller; A M Eisentraut
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

View more
  44 in total

1.  Portacaval shunt and hyperlipidemia.

Authors:  T E Starzl; C W Putnam; L J Koep
Journal:  Arch Surg       Date:  1978-01

2.  Interaction of 4-hydroxynonenal-modified low-density lipoproteins with the fibroblast apolipoprotein B/E receptor.

Authors:  W Jessup; G Jurgens; J Lang; H Esterbauer; R T Dean
Journal:  Biochem J       Date:  1986-02-15       Impact factor: 3.857

3.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

Authors:  J L Goldstein; Y K Ho; S K Basu; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

4.  Detection of the low-density-lipoprotein receptor with biotin-low-density lipoprotein. A rapid new method for ligand blotting.

Authors:  D P Wade; B L Knight; A K Soutar
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

5.  Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool sizes.

Authors:  D J McNamara; E H Ahrens; R Kolb; C D Brown; T S Parker; N O Davidson; P Samuel; R M McVie
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

Authors:  D W Bilheimer; S M Grundy; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

7.  Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.

Authors:  J M Hoeg; S J Demosky; E J Schaefer; T E Starzl; H B Brewer
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

8.  Cholesterol homeostasis in the rat with a portacaval anastomosis.

Authors:  A Proia; D J McNamara; K D Edwards; E H Ahrens
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

9.  Portacaval shunt in patients with familial hypercholesterolemia.

Authors:  T E Starzl; H P Chase; E H Ahrens; D J McNamara; D W Bilheimer; E J Schaefer; J Rey; K A Porter; E Stein; A Francavilla; L N Benson
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

10.  Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.

Authors:  H N Ginsberg; N A Le; M P Short; R Ramakrishnan; R J Desnick
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.